Bausch health provides update on strategic alternatives

Laval, qc / access newswire / february 6, 2025 / bausch health companies inc. (nyse:bhc)(tsx:bhc) (the "company" or "bausch health"), a global, diversified pharmaceutical company enriching lives through a relentless drive to deliver better health outcomes, issued the following update on a potential sale of its subsidiary, bausch + lomb corporation (nyse:blco)(tsx:blco), which was disclosed in december 2024 following a regulatory request: "in the second half of 2024, bausch health engaged with its financial advisors to work on various liability management alternatives. at the same time, bausch + lomb was approached by a private equity firm with an indication of interest for a potential sale of bausch + lomb at a compelling valuation.
BLCO Ratings Summary
BLCO Quant Ranking